Status:

COMPLETED

Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2

Lead Sponsor:

University of Alabama at Birmingham

Collaborating Sponsors:

National Institutes of Health (NIH)

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Infant,Premature

Eligibility:

All Genders

1-15 years

Phase:

NA

Brief Summary

To determine if late (at or beyond postnatal day 14) mild permissive hypercapnia is associated with reduction in apnea, bradycardia, and hypoxemic episodes and with improved stability of oxygenation.

Detailed Description

Preterm infants who remain intubated or on nasal mechanical ventilation (IMV) at 14 days postnatal age, meet blood gas criteria, have transcutaneous carbondioxide (TcCO2) monitoring with TcCO2 values ...

Eligibility Criteria

Inclusion

  • Inborn infants weighing 401-1,000 grams on admission and/or 22w 0/7d to 28w 6/7d (\<29 weeks) inclusive completed weeks of gestation
  • Infants eligible for full care and resuscitation as necessary, and surviving beyond 24 h of age
  • Enrollment in main study protocol (Aim 1 of PreVENT Apnea) at \<1 week post-natal age
  • Informed consent from parent/guardian
  • This study will enroll the subset of infants from Aim 1 who are still intubated or on nasal IMV at 2 weeks postnatal age, meet blood gas criteria (arterial or capillary arterialized blood gas values done q12-24h, as most infants do not have an arterial line at 2 weeks: pH \>7.25, PaCO2 \>40 mm Hg), have TcCO2 monitoring with TcCO2 values that trend and correlate appropriately with PaCO2, and are not judged too unstable by the Attending neonatologist.

Exclusion

  • Refusal or withdrawal of consent
  • Major congenital malformations (e.g., not including patent ductus arteriosus, small hernia)

Key Trial Info

Start Date :

April 9 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 30 2021

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT03333161

Start Date

April 9 2018

End Date

March 30 2021

Last Update

September 21 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Regional Neonatal ICU and CCN, University of Alabama at Birmingham

Birmingham, Alabama, United States, 35233